Nilogen Oncosystems Alternatives & Competitors

12 companies similar to Nilogen Oncosystems — We analyze cancer drug responses using fresh patient tumor tissue with intact tu...

Farcast Biosciences

24,000 human tumors and counting - building the most precise functional precision tumor mi...

38 Pre-Seed $74.63M

Bengaluru, India

Biotechnology Health Care +1

Personalis, Inc.

Ultrasensitive ctDNA testing

429 IPO $409.80M

Fremont, United States

Biotechnology Health Care

VitroScan

Predictive Testing Solutions

10 Grant $2.70M

Leiden, The Netherlands

Biopharma Biotechnology +4

Lodestone Biomedical Inc.

Immediate detection of immune response from the tumor microenvironment to accelerate cance...

3 Non Equity Assistance

Lebanon, United States

Biotechnology Health Care

Rival Readout

Competing with Nilogen Oncosystems? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Strata Oncology

31 Series C $128.00M

Ann Arbor, United States

Biotechnology Health Care +1

Avenzo Therapeutics

Developing the next generation of oncology therapies for patients

61 $661.00M

San Diego, United States

Biotechnology Health Care +1

PathAI

Improving patient outcomes with AI-powered pathology.

277 Debt Financing $355.20M

Boston, United States

Biotechnology Health Care

Compare

Helomics

Bringing personalized healthcare to the forefront of oncology with advanced diagnostics an...

11-50 Corporate Round $211.50M

Biotechnology Health Care +1

N-of-One, Inc.

Relevant, timely precision oncology treatment options drive real world impact. N-of-One is...

9 Series B $12.45M

Lexington, United States

Biotechnology Health Care

IntegraGen

Company specializing in the genomics of cancer and genetic diseases

50 Post-IPO Equity $12.40M

Evry, France

Biotechnology Health Care +1

Quanta Therapeutics

35 Series D $140.70M

Biotechnology Health Care +2

ORIC Pharmaceuticals Inc.

Overcoming Resistance In Cancer

119 Post-IPO Equity $408.00M

South San Francisco, Unit...

Biopharma Biotechnology +3

About Nilogen Oncosystems

Nilogen Oncosystems is a biotechnology and healthcare company based in the United States that was founded in 2013. The company's primary focus is on revolutionizing cancer drug development and immuno-oncology. Their slogan, "We analyze cancer drug responses using fresh patient tumor tissue with intact tumor microenviro...

Business keywords

Cancer Drug Development, Immuno-oncology, Precision Medicine, Tumor Microenvironment Analysis, Preclinical Drug Testing, Companion Diagnostics, CLIA-certified Lab, Ex Vivo Drug Responses, Contract Research Organization, Pharmaceutical Services, Biotechnology Services, Molecular Mechanisms, Clinical Trials, Data Interpretation

Frequently Asked Questions

Companies similar to Nilogen Oncosystems include Farcast Biosciences, Personalis, Inc., VitroScan, Lodestone Biomedical Inc., Strata Oncology. They work in Biotechnology and Health Care and share Nilogen Oncosystems's focus on precision medicine, clinical trials and immuno-oncology.

Bounce Watch lists 12 companies that share Nilogen Oncosystems's industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Nilogen Oncosystems: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Nilogen Oncosystems Profile Farcast Biosciences Alternatives Personalis, Inc. Alternatives VitroScan Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Nilogen Oncosystems on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.